CL Item
Glatirameracetat (Copaxone) (Glatirameracetat)
(Comment:en)
C1236476 (UMLS CUI-1)
(Comment:de)
CL Item
(PEG-Interferon-ß 1a s.c.)
CL Item
(Interferon-ß 1b s.c.)
CL Item
(Interferon-ß 1a s.c.)
CL Item
(Interferon-ß 1a i.m)
CL Item
(No therapy)
C0746919 (UMLS CUI-1)
(Comment:de)
CL Item
(Other)
C2827774 (UMLS CUI-1)
C0205394 (UMLS CUI-2)
(Comment:de)
CL Item
Medikation aus einer MS-Studie (Study Medication)
C0304229 (UMLS CUI-1)
(Comment:de)
CL Item
(Recurrent steroide pulse therapy)
C0587279 (UMLS CUI-1)
(Comment:de)
CL Item
(Methotrexate)
C0025677 (UMLS CUI-1)
(Comment:de)
CL Item
(Cyclophosphamide)
C0010583 (UMLS CUI-1)
(Comment:de)
CL Item
(IVIg)
C0085297 (UMLS CUI-1)
(Comment:de)
CL Item
(Azathioprine)
C0004482 (UMLS CUI-1)
(Comment:de)
CL Item
(Mitoxantrone)
C0026259 (UMLS CUI-1)
(Comment:de)
CL Item
Tocilizumab (Tocilizumab)
C1609165 (UMLS CUI-1)
(Comment:de)
CL Item
(Rituximab)
C0393022 (UMLS CUI-1)
(Comment:de)
CL Item
(Ocrelizumab)
C1882138 (UMLS CUI-1)
(Comment:de)
CL Item
(Daclizumab)
C0663182 (UMLS CUI-1)
(Comment:de)
CL Item
Alemtuzumab (Lemtrada) (Alemtuzumab)
(Comment:en)
C0383429 (UMLS CUI-1)
(Comment:de)
CL Item
Natalizumab (Tysabri) (Natalizumab)
(Comment:en)
C1172734 (UMLS CUI-1)
(Comment:de)
CL Item
(Fingolimod)
(Comment:en)
C1699926 (UMLS CUI-1)
(Comment:de)
CL Item
(Teriflunomide)
(Comment:en)
C1718383 (UMLS CUI-1)
(Comment:de)
CL Item
Fumarate (BG-12; Tecfidera) (Fumarate)
(Comment:en)
C0058218 (UMLS CUI-1)
(Comment:de)